Roche has launched its DISCOVERY 5-Plex procedure and reagents to be used for immunohistochemistry (IHC) research applications.
The pre-optimised, fully automated multiplex procedure is applicable on the VENTANA DISCOVERY ULTRA2 instrument.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Roche's DISCOVERY product line is a research-use-only (RUO) portfolio of instruments and reagents for research in immunohistochemistry (IHC) and in situ hybridisation (ISH).
A part of the Discovery product portfolio, the DISCOVERY ULTRA research instrument is designed to fully automate single or multiplex IHC and ISH applications and a growing line of reagents for full automation designed to meet the needs of the research community.
The DISCOVERY 5-Plex procedure enables the researchers to investigate up to five biomarkers on a single slide, preserving tissue and maximising data.
It facilitates the researchers with a pre-optimised workflow to simplify the staining process. The ready-to-use detection reagents offers crisp, specific signals and distinct information about protein co-expression patterns.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataRoche Tissue Diagnostics head Ann Costello said: "To better investigate the complexities of cancer biology and possible treatment strategies, it is increasingly important to detect multiple biomarkers on a single slide.
"The launch of the innovative DISCOVERY 5-Plex procedure advances automation in multiplexing technology, which is expected to play a critical role in cancer research in the future."
The launch of the DISCOVERY 5-Plex procedure will be followed by the commercial launch of the DISCOVERY FAM Kit, DISCOVERY Rhodamine 6G Kit, DISCOVERY Red 610 Kit, and DISCOVERY DCC Kit.
